⌘K
Loading ticker…
As of 2026-08-24, Armata Pharmaceuticals, Inc. Common Stock (ARMP) has a 3-month relative strength percentile of 10 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 46. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 11.5%, relative volume 0.62×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
ARMP is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $2M notional.
Held by 3 ETFs · $4M across latest filings · largest weight 0.01% (IWC).
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $2M | — |
| VXFVanguard Extended Market ETF | 0.00% | $1M | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ARMP Jan avg: 43.02% median: 12.54% win: 100% σ: 65.03% n: 4 2022-04-12 → 2026-07-31 | ARMP Feb avg: 12.85% median: 1.61% win: 50% σ: 32.57% n: 4 2022-04-12 → 2026-07-31 | ARMP Mar avg: -15.30% median: -15.65% win: 25% σ: 19.33% n: 4 2022-04-12 → 2026-07-31 | ARMP Apr avg: -9.06% median: -2.99% win: 20% σ: 18.02% n: 5 2022-04-12 → 2026-07-31 | ARMP May avg: -3.82% median: -12.98% win: 40% σ: 17.89% n: 5 2022-04-12 → 2026-07-31 | ARMP Jun avg: -8.04% median: -3.14% win: 20% σ: 9.29% n: 5 2022-04-12 → 2026-07-31 | ARMP Jul avg: 25.11% median: 5.91% win: 80% σ: 56.23% n: 5 2022-04-12 → 2026-07-31 | ARMP Aug avg: 6.50% median: -0.07% win: 50% σ: 22.52% n: 4 2022-04-12 → 2026-07-31 (current) | ARMP Sep avg: 1.84% median: 0.73% win: 50% σ: 13.72% n: 4 2022-04-12 → 2026-07-31 | ARMP Oct avg: 1.61% median: -13.77% win: 25% σ: 43.84% n: 4 2022-04-12 → 2026-07-31 | ARMP Nov avg: 3.76% median: -1.55% win: 25% σ: 33.42% n: 4 2022-04-12 → 2026-07-31 | ARMP Dec avg: -6.06% median: -16.95% win: 25% σ: 37.45% n: 4 2022-04-12 → 2026-07-31 |